MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Limiting eligibility for medical studies

Back to society news Blogs list Cancer blog  


Subscribe To Society News RSS Feed  RSS content feed What is RSS feed?

Limiting eligibility for medical studies

Limiting eligibility for medical studies
A new analysis has observed that a number of alcohol therapy studies are designed in ways that inadvertently omit women and African-Americans from participation. The Stanford University School of Medicine researcher who led the effort said the findings should remind all researchers that strict study eligibility criteria can have unintended, negative consequences.

In reviewing data from a pool of 100,000 alcohol therapy patients, Keith Humphreys, PhD, professor of psychiatry and behavioral sciences, determined that women and African-Americans were substantially more likely to be excluded from therapy studies than men or non-African-American patients, because of eligibility requirements involving psychiatric problems, employment and housing problems, and drug use.

"Researchers' own study designs are thwarting their good-faith efforts to recruit representative patient samples," said Humphreys, whose paper would be reported in the recent issue of Alcoholism: Clinical and Experimental Research. "If we want health-care practice to be guided by research, we're going to have to do a better job at studying patients that clinicians actually see".

Medical studies typically exclude certain patients from participation. While some exclusions are often necessary - to protect patient safety, for example - Humphreys suspects scientists often use exclusions in their studies out of habit or tradition. In other cases, scientists may use eligibility criteria to enroll only "desirable" patients in their study, in an effort to make the trial run smoothly or to increase the chances that a favored therapy will show positive outcomes.

Humphreys said such exclusions could have dangerous implications. "If therapys are tested on, and developed for, only part of the population, that means everyone excluded is at greater risk when they use health care," said Humphreys. For this reason, the National Institutes of Health has instructed scientists to design their studies to ensure adequate enrollment of all populations, including women and racial minorities.

"The NIH, and we as a society, have decided that the burden and benefits of health research should be shared by everyone," said Humphreys, who is also on the staff of the Veterans Affairs Palo Alto Health Care System. "It's a moral and political stance and we're obligated to live up to it".

For the analysis, Humphreys and colleagues looked at data sets from five prior alcohol therapy studies that enrolled more than 100,000 patients. They then explored the impact of six exclusion criteria usually used in therapy outcome research: psychiatric problems, neurological problems, medical problems, drug use, non-compliance issues, and social and residential instability.

The scientists observed that women were 62 percent more likely than men to be disqualified from studies that mandatory social and residential stability. Women were 29 percent more likely to be excluded from studies that disqualified patients with psychiatric problems, and 20 percent more likely to be excluded for medical problems.

They also observed that African-Americans were 46 percent more likely than non-African-Americans to be excluded from studies that mandatory social and residential stability, and 23 percent more likely to be excluded based on drug-use criteria.

"The end result can be a sample that over-represents Caucasian males relative to the therapy population," the authors noted in their paper.

Humphreys stressed that he doesn't believe his fellow scientists are acting out of prejudice or purposefully excluding patients. "Most scientists want women in the studies, but they don't realize that the way they design the study undermines their intentions," he said. "A researcher may say, 'I don't want anyone who is depressed in my alcohol study,' and not stop to consider that the majority of depressed people are women".

Based on the paper's findings, Humphreys said he would encourage scientists to carefully examine the rationale of a study's eligibility criteria. "Scientists need to say to themselves, 'I'm only going to make the decision to exclude certain patients if there is a good reason for it,'" he said.

Humphreys and colleagues are also urging designers of alcohol therapy studies to stop excluding patients with drug problems. "Eighty percent of patients with alcohol problems use some sort of drug, so there is a strong case for including these patients in studies," he said.


Posted by: Janet    Source




Did you know?
A new analysis has observed that a number of alcohol therapy studies are designed in ways that inadvertently omit women and African-Americans from participation. The Stanford University School of Medicine researcher who led the effort said the findings should remind all researchers that strict study eligibility criteria can have unintended, negative consequences.

Medicineworld.org: Limiting eligibility for medical studies

Asthma| Hypertension| Medicine Main| Diab french| Diabetes drug info| DruginfoFrench| Type2 diabetes| Create a dust free bedroom| Allergy statistics| Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.